FB Financial (NYSE:FBK) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 7.59 percent. This is a 4.49 percent decrease over earnings of $0.89 per share from the same period last year.
Citigroup Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $6
Citigroup analyst Samantha Semenkow initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $6.
